Document is current
Any future updates will be listed below
-
Authors
Conversano, Francesco
Pisani, Paola
Casciaro, Sergio
-
Funding
Funding for this research was provided by:
Consiglio Nazionale Delle Ricerche
- License Information
-
More Information
Article History
Received: 18 April 2026
Accepted: 4 May 2026
First Online: 19 May 2026
Declarations
:
: Sergio Casciaro is Founder and CEO of Echolight SpA, Lecce, Italy, and owns stocks of Echolight SpA. Francesco Conversano is Co-founder and CTO of Echolight SpA, Lecce, Italy, and owns stocks of Echolight SpA.
: This paper consisted of a retrospective methodological analysis performed only on de-identified previously acquired REMS data. Patients had provided written informed consent at the time of data acquisition, including consent for the use of de-identified data for subsequent analyses. No new patient contact, intervention, or collection of identifiable data was performed for the present study. A blank/anonymized copy of the typically adopted informed consent form is provided as Supplementary File .
